Daewoong Pharmaceutical’s Ursa challenges U.S. market with new look

‘Ursa’ will have a new look in 58 years of its launch. Daewoong Pharmaceutical is currently taking a new direction to renew the product which has grown 20% up in sales for the past 3 years.

With the uptrend, it is also planning to enter other advanced markets, like the U.S., beyond the No.1 Liver Drug’ in Korea.

According to Daewoong Pharmaceutical, the company is developing the ‘next-generat...